Quercetin Composition for Addiction Treatment

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current treatments for addiction do not effectively manage withdrawal symptoms and long-term dependency on substances or activities, as they fail to sustainably reduce the need for euphoric substances and address underlying mitochondrial deficiencies.

Innovation Solution

A composition containing quercetin, preferably combined with vitamin B3 and vitamin C, is administered to subjects to block neurotransmitter re-uptake, increasing their plasma concentration and half-life, thereby reducing withdrawal symptoms and dependency by enhancing mitochondrial function.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If current addiction treatments are used, then immediate withdrawal management may be achieved, but long-term dependency reduction and sustainable treatment effectiveness are insufficient

Engineering Contradiction:
Improvelong-term treatment effectivenessVSAvoidsustainable reduction of substance need
Core Design Contradiction:
ReliabilityVSDuration of action of stationary object

Solution Approach 1:

The patent applies preliminary action by administering quercetin before and during the addiction treatment process to prevent mitochondrial damage and oxidative stress that would otherwise occur during withdrawal. This proactive approach ensures mitochondrial function is protected in advance, enabling sustained long-term effectiveness rather than just temporary withdrawal management.

Inventive Principle:
Principle #10Preliminary action

Solution Approach 2:

The patent changes the biochemical parameters of treatment by introducing quercetin, which modifies mitochondrial function, reduces oxidative stress, and alters neurotransmitter metabolism. These parameter changes in mitochondrial health and antioxidant capacity create sustainable long-term effects that reduce dependency rather than providing temporary relief.

Inventive Principle:
Principle #35Parameter changes

2Object-affected harmful factors

If conventional addiction treatments are administered, then withdrawal symptoms may be temporarily managed, but underlying mitochondrial deficiencies are not addressed

Engineering Contradiction:
Improvewithdrawal symptomsVSAvoidaddressing underlying causes
Core Design Contradiction:
Object-affected harmful factorsVSReliability

Solution Approach 1:

The patent uses quercetin as an intermediary substance that mediates between the addictive substance withdrawal and the body's mitochondrial systems. Quercetin acts as a bridge that protects mitochondrial function during withdrawal, reducing harmful symptoms while simultaneously addressing the underlying mitochondrial deficiencies through its antioxidant and anti-inflammatory properties.

Inventive Principle:
Principle #24Intermediary (Mediator)

Solution Approach 2:

The patent converts the harmful oxidative stress and mitochondrial damage that normally occur during addiction withdrawal into a beneficial treatment opportunity. By administering quercetin, the harmful free radicals and oxidative stress are transformed into a controlled therapeutic process that strengthens mitochondrial function and reduces dependency, turning the withdrawal crisis into a healing opportunity.

Inventive Principle:
Principle #22Blessing in disguise (Convert harm into benefit)

3Reliability

If quercetin is administered alone, then some anti-addiction effect may be achieved, but plasma concentration and half-life are insufficient for optimal effectiveness

Engineering Contradiction:
Improveanti-addiction efficacyVSAvoidplasma half-life of quercetin
Core Design Contradiction:
ReliabilityVSDuration of action of moving object

Solution Approach 1:

The patent merges quercetin with vitamin B3 (niacin) and vitamin C to create a synergistic combination. Vitamin B3 enhances quercetin's ability to cross the blood-brain barrier and increases its plasma half-life, while vitamin C provides additional antioxidant support. This merging of substances creates a more effective and sustained treatment than quercetin alone.

Inventive Principle:
Principle #5Merging (Combining)

Solution Approach 2:

The patent changes the pharmacokinetic parameters of quercetin by combining it with vitamin B3 and vitamin C. This combination increases quercetin's plasma concentration, extends its half-life, and enhances its bioavailability. The parameter changes in absorption, distribution, and elimination profiles result in optimal effectiveness for treating addiction.

Inventive Principle:
Principle #35Parameter changes

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The quercetin and vitamin B3/C composition effectively reduces the need for addictive substances, alleviates withdrawal symptoms, and improves mitochondrial health, providing a sustainable treatment for addiction and associated disorders.

Implementation Method 1

block neurotransmitter re-uptake, increasing their plasma concentration and half-life

Methodology Applied
Scientific EffectNeurotransmitter re-uptake inhibition:

Implementation Method 2

enhancing mitochondrial function

Methodology Applied
Scientific EffectMitochondrial function enhancement:

Implementation Method 3

Quercetin, a natural antioxidant, is known to inhibit both acute and chronic phases of free-radical induced diseases

Methodology Applied
Scientific EffectAntioxidant activity: Oxidation

Data Source

PatentUS8507548B2Method for treating addiction using quercetin-containing compositions
Publication Date: 2013.08.13 QUERCIS PHARMA AG

AI summary

This invention relates to a method of treating addiction using a composition containing quercetin. Preferably, it also contains vitamin B3, and vitamin C.